NRG-BR003 Archives - NRG Oncology

‘NRG-BR003’ of page ‘NRG-BR003’

BR003 Site Initiation Visit (SIV) BR003 Certification of Completion Certificate (For Canadian Sites Only)

‘NRG-BR003: A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer’ of page ‘NRG-BR003’

Principal Investigator Vicente Valero, MD Primary Objective To determine whether the addition of carboplatin to an adjuvant chemotherapy regimen of doxorubicin/cyclophosphamide followed by paclitaxel will improve the invasive disease-free survival (IDFS) compared to doxorubicin/cyclophosphamide followed by paclitaxel when administered to patients with operable node-positive or high-risk node-negative triple-negative breast cancer. Patient Population Patients with operable […]

Content Block Tag: NRG-BR003

‘NRG-BR003’ of page ‘NRG-BR003’

‘NRG-BR003: A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer’ of page ‘NRG-BR003’